GYN Cancers Highlighted in UK Campaign

Manchester company helps raise awareness of Gynae Cancer

A Manchester cervical cancer diagnostic company is helping to raise awareness of the five gynaecological cancers – womb, ovarian, cervical, vaginal and vulval – in support of Gynaecological Cancer Awareness Month.

Background

Throughout September, Manchester, UK – based Zilico  is supporting the UK campaign run by The Eve Appeal, to help more people become aware of the early signs and symptoms. Zilico is itself the developer of a proprietary diagnostic system for cervical cancer.

In engaging with this campaign the company has spoken to clinicians, patients and partners to talk about their experiences and has been highlighting these stories on social media throughout the month.

In the UK alone each year, there are over 21,000 women who are given the news that they have a form of gynaecological cancer. This equates to 58 women being diagnosed daily. Of those diagnosed, sadly 21 women every day will lose their battle.

UK charity, The Eve Appeal is determined to change this. Part of the charity’s mission is to ensure that both women and men are aware of what to look out for. The Eve Appeal reports that there is a lack of basic knowledge about the female body, as well as conversations around how the female anatomy works.

Gynae Month aims to help educate women about their body and let them know what to look out for in terms of unexpected changes in their vagina or vulva, as well as being aware of the signs and symptoms of a gynaecological cancer.

Company comments

Sameer Kothari, CEO of Zilico said: “I admire the work of The Eve Appeal as it helps raise awareness of gynae cancers. Too many women are diagnosed with gynae cancers each year so it’s important that both women and men know what to look out for.”

To help people become more body aware, The Eve Appeal has released a video, which explains all about gynae cancers here.

published: September 21, 2017 in: Gynaecology/Obstetrics, News

Leave a Reply

Your email address will not be published. Required fields are marked *

Most read

Latest

^